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We report a case of a 54-year-old obese, loudly snoring male, who presented to the hospital
with typical ischemic chest pain of early morning onset, and high blood pressure values.
A standard 12-lead ECG performed on admission showed ST-segment elevation in leads II,
III, aVF, V1 and ST-segment depression in leads I, aVL, V2 to V4, but coronary angiography
revealed no evidence of plaque rupture or erosion in an epicardial coronary vessel.
Performed polysomnography confirmed severe obstructive sleep apnea (OSA). According
to the universal definition of myocardial infarction patient was diagnosed with acute
ST-segment elevation myocardial infarction type 2, caused probably by sudden blood
pressure rise secondary to apnea episode in the course of OSA. Patient was treated with
continuous positive airway pressure device and suffered no further adverse cardiovascular
event during 12 months of follow-up. The case highlights importance of further investiga-
tion of novel risk factors such as OSA, and possibly listing it as one of the causes of acute
myocardial infarction type 2.
& 2013 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o. All
rights reserved.
.1. Introduction
Obstructive sleep apnea (OSA) is one of the most common
sleep disturbances. It increases the risk for development of
hypertension, coronary heart disease, stroke or metabolic
disorders [1,2]. It is proven of being responsible for type 1 and
type 4b myocardial infarction [3,4].
We report a case of 54-year-old obese male admitted to the
hospital, because of an acute chest pain. The pain occurred at
dawn (about 4:30 am) and woke patient up from his sleep.
Patient was transferred by an ambulance to the emergency
room, where physical examination revealed blood pressure of
180/110 mmHg, and body mass index 35.2 kg/m2. A standard
12-lead electrocardiography showed normal sinus rhythmch Society of Cardiology.
58; fax: þ48 22 599 19 57.
lip.szymanski@wum.eduwith a rate 96 beats per minute, ST-segment elevation in
leads II, III, aVF, V1 and ST-segment depression in leads I, aVL,
V2 to V4 (Fig. 1). Patient was transferred directly to the
catheterization laboratory, where coronary angiography
showed no evidence of plaque rupture or erosion in an
epicardial coronary vessel. In laboratory tests performed on
admission we noted: troponin I elevated to 4.7 ng/ml (norm,
o0.1 ng/ml), CK-MB mass 14.3 ng/ml (norm, o3.6 ng/ml),
C-reactive protein (CRP) 13.4 mg/l (norm, 0–10 mg/l), LDL
cholesterol 151mmd/dl, total cholesterol 206mg/dl (norm,
120–200mg/dl), hemoglobin 14.9 g/dl (norm, 14–18 g/dl), plate-
lets 218103/ml (norm, 15040010 /3 ml) and glucose 131mg/dl
(norm, 65–110mg/dl) with HbA1C 6.3% (norm, o6.5%). Echocar-
diography (Philips iE-33, Philips Medical Systems, Eindhoven,Published by Elsevier Urban & Partner Sp.z o.o. All rights reserved.
.pl (F.M. Szymanski).
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Fig. 1 – The initial standard electrocardiogram performed on admission.
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hypokinesis of the intraventricular septum, and left ventricular
ejection fraction 41%. Patient received clopidogrel 75 mg/day,
acetylosalicid acid 75mg/day, atorvastatin 40mg/day, amlodi-
pine 5mg/day, valsartan 160mg/day, eplerenon 25mg/day,
bisoprolol 5 mg/day, and pantoprazole 20mg/day.
Additional medical history obtained from patient’s wife
revealed that he has had sleep disturbances. Patient had also
complained on general fatigue during the day. Patient’s spouse
reports that on the night of the event, he had snored loudly and
had especially long episode of apnea prior directly to the arousal
with chest pain. Those symptoms suggested possibility of OSA
in our patient. After few days of recovery patient underwent
sleep study (Embletta X100; Flaga, Reykjavik, Iceland), which
confirmed the initial diagnosis, and showed a severe case of
OSA [apnea hypopnea index (AHI) 41 per hour, mean oxygen
saturation during sleep 93%, total time of saturation o90% was
15.8 min, mean heart rate during sleep 58 beats per minute]
(Fig. 2). The patient underwent a 24-h Ambulatory Blood
Pressure Monitoring (ABPM) that provided mean daytime pres-
sures of 146/87mmHg, mean nighttime values of 142/94mmHg
and mean morning value 153/93mmHg (Fig. 3). We excluded
also other possible causes of secondary/resistant hypertension
(e.g. renal artery stenosis, pheochromocytoma).
Patient was treated with a continuous positive airway
pressure [CPAP (S9 AutoSet)], and discharged home with a
diagnosis of type 2 acute myocardial infarction (AMI), hyper-
tension, OSA, and obesity.
He tolerates CPAP well (average daily usage 7.21 h) which
allowed better blood pressure control. 3 months after AMI we
repeat polysomnography, which showed mild OSA. The result of
ABPM provided mean daytime blood pressure of 120/77mmHg
and nighttime of 100/60 mmHg—dipper profile. After one year
the patient was followed up by their physician by regular
visits. He was in good general condition with no further
adverse cardiovascular events.2. Discussion
According to the newest, third universal definition of myo-
cardial infarction, AMI is divided into 5 types based on acausative factor [3]. The most common one is type 1 related
to atherosclerotic plaque rupture, ulceration, fissuring,
erosion, or dissection. Type 2 refers to an AMI caused by
coronary endothelial dysfunction, coronary artery spasm,
coronary embolism, tachy-brady-arrhythmias, anemia,
respiratory failure, hypotension, or as in our patient’s case
hypertension. We excluded other possible causes of AMI. It is
reported that about 3% of patients with AMI (not related to
PCI, CABG or stent thrombosis) have no evidence of plaque
rupture or erosion in an epicardial coronary vessel and
therefore can be classified as type 2 AMI [5]. But some studies
show that even up to 28% of patients with AMI can be
classified as type 2 [5]. Due to variety of type 2 AMI causes,
patients afflicted with this disease can have different clinical
characteristics, but up to this day there were very few major
studies trying to describe their common features. We only
know that type 2 AMI patients have more comorbidities,
lower mean peak troponin I values, and a lower rate of
ST-segment elevation than type 1 AMI patients [6].
In our patient a series of unfortunate events contributed
to development of one another. The patient was severely
obese, which lead to an increased risk of developing OSA.
OSA promotes hypertension development by constant stimu-
lation of sympathetic system. During night time patient had
many episodes of apnea followed by microarousals. At the
initial phase of every apnea episode patient’s airways were
getting obstructed and ventilation was blocked, there was a
desaturation, and a drop in blood pressure value. Triggered,
reflexive mechanisms resulted in arousal, with sudden and
high blood pressure and heart rate value rise. One of elevated
blood pressure episodes probably caused type 2 AMI.
If the clinic blood pressure is 140/90mmHg or higher, the new
National Institute for Health and Clinical Excellence guideline,
offers ABPM to confirm the diagnosis of hypertension. The ABPM
is superior to clinic measurement in predicting cardiovascular
mortality. The nighttime blood pressure is the most potent
predictor of outcome. In our patient, the results of the ABPM
showed non-dipper profile with morning blood pressure surge.
Other possible cause of type 2 AMI is impaired oxygen
supply. Can constant desaturation, in this case, be so severe
to cause AMI? We cannot find out retrospectively, but we are
sure that prolonging desaturation, was followed by hypoxia,
Fig. 2 – The baseline polysomnography summary graph.
Fig. 3 – The baseline Ambulatory Blood Pressure Monitoring summary graph.
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with activation of inflammation, as well as impairment of
endothelial repair mechanisms, which are present in OSA,
gives endothelial dysfunction, found to play a major role in
atherogenesis, and development of variety of cardiovascular
disease [7]. Another factor that may suggest that AMI was
caused by OSA is the time of the pain onset. The odds of AMI
occurring between midnight and 6 am are much higher in
patients with OSA than in those without [8].
Treatment of OSA with CPAP contributes to better manage-
ment of hypertension, prevents sudden blood pressure rises
and gives better control of metabolic disorders [1]. In our
patient it also probably prevented further adverse coronary
events from happening. That suggests that OSA may be
responsible for more diseases than we previously thought.
It may be a primary cause not only of resistant hypertension,
coronary artery disease, or erectile dysfunction but also type 2
AMI. Our patient’s case illustrates that there is still a need for
further investigation of novel cardiovascular disease risk fac-
tors such as OSA. Possibly, OSA should be listed as one of the
cause of type 2 AMI.Conflict of interest
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